ORAMED PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Oramed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q2 2021 to Q3 2025.
  • Oramed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending September 30, 2025 was $129K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)

ORAMED PHARMACEUTICALS INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $129K Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $129K Jun 30, 2025 10-Q 2025-08-14
Q4 2023 $10K $0 0% Dec 31, 2023 10-K 2024-03-06
Q3 2023 $9K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $118K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $120K -$4K -3.23% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $10K Dec 31, 2022 10-Q 2023-11-09
Q1 2022 $124K Mar 31, 2022 10-Q 2023-05-11
Q2 2021 $134K May 31, 2021 10-Q 2021-07-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.